218 related articles for article (PubMed ID: 29190391)
1. Radiotherapy for locally advanced resectable T3-T4 laryngeal cancer-does laryngeal preservation strategy compromise survival?
Yamazaki H; Suzuki G; Nakamura S; Hirano S; Yoshida K; Konishi K; Teshima T; Ogawa K
J Radiat Res; 2018 Jan; 59(1):77-90. PubMed ID: 29190391
[TBL] [Abstract][Full Text] [Related]
2. Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study.
Lefebvre JL; Pointreau Y; Rolland F; Alfonsi M; Baudoux A; Sire C; de Raucourt D; Malard O; Degardin M; Tuchais C; Blot E; Rives M; Reyt E; Tourani JM; Geoffrois L; Peyrade F; Guichard F; Chevalier D; Babin E; Lang P; Janot F; Calais G; Garaud P; Bardet E
J Clin Oncol; 2013 Mar; 31(7):853-9. PubMed ID: 23341517
[TBL] [Abstract][Full Text] [Related]
3. [Effective analysis of non-surgical combined treatments for laryngeal organ preservation in locally advanced laryngeal carcinoma].
Yan F; Zhang X; Ma L; Liu M; Chen N; Wang J; Wu W; Huang D
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 51(5):372-7. PubMed ID: 27220298
[TBL] [Abstract][Full Text] [Related]
4. Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II.
Dietz A; Wichmann G; Kuhnt T; Pfreundner L; Hagen R; Scheich M; Kölbl O; Hautmann MG; Strutz J; Schreiber F; Bockmühl U; Schilling V; Feyer P; de Wit M; Maschmeyer G; Jungehülsing M; Schroeder U; Wollenberg B; Sittel C; Münter M; Lenarz T; Klussmann JP; Guntinas-Lichius O; Rudack C; Eich HT; Foerg T; Preyer S; Westhofen M; Welkoborsky HJ; Esser D; Thurnher D; Remmert S; Sudhoff H; Görner M; Bünzel J; Budach V; Held S; Knödler M; Lordick F; Wiegand S; Vogel K; Boehm A; Flentje M; Keilholz U
Ann Oncol; 2018 Oct; 29(10):2105-2114. PubMed ID: 30412221
[TBL] [Abstract][Full Text] [Related]
5. A change in the study evaluation paradigm reveals that larynx preservation compromises survival in T4 laryngeal cancer patients.
Dyckhoff G; Plinkert PK; Ramroth H
BMC Cancer; 2017 Sep; 17(1):609. PubMed ID: 28863776
[TBL] [Abstract][Full Text] [Related]
6. Induction chemotherapy followed by cisplatin or cetuximab concomitant to radiotherapy for laryngeal/hypopharyngeal cancer: Long-term results of the TREMPLIN randomised GORTEC trial.
Janoray G; Pointreau Y; Alfonsi M; Sire C; Geoffrois L; de Raucourt D; Bardet E; Calais MH; Garaud P; Calais G
Eur J Cancer; 2020 Jul; 133():86-93. PubMed ID: 32454417
[TBL] [Abstract][Full Text] [Related]
7. Induction chemotherapy followed by radiotherapy for larynx preservation in advanced laryngeal and hypopharyngeal cancer: Outcome prediction after one cycle induction chemotherapy by a score based on clinical evaluation, computed tomography-based volumetry and
Wichmann G; Krüger A; Boehm A; Kolb M; Hofer M; Fischer M; Müller S; Purz S; Stumpp P; Sabri O; Dietz A; Kluge R
Eur J Cancer; 2017 Feb; 72():144-155. PubMed ID: 28033526
[TBL] [Abstract][Full Text] [Related]
8. Induction chemotherapy-based larynx preservation program for locally advanced hypopharyngeal cancer: oncologic and functional outcomes and prognostic factors.
Bozec A; Benezery K; Ettaiche M; Chamorey E; Vandersteen C; Dassonville O; Poissonnet G; Riss JC; Hannoun-Lévi JM; Chand ME; Leysalle A; Saada E; Guigay J; Sudaka A; Demard F; Santini J; Peyrade F
Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3299-306. PubMed ID: 26858198
[TBL] [Abstract][Full Text] [Related]
9. Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study.
Mesía R; Garcia-Saenz JA; Lozano A; Pastor M; Grau JJ; Martínez-Trufero J; Lambeaz J; Martínez-Galán J; Mel JR; González B; Vázquez S; Mañós M; Taberna M; Cirauqui B; Del Barco E; Casado E; Rubió-Casadevall J; Rodríguez-Jaráiz A; Cruz JJ;
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):473-480. PubMed ID: 28011050
[TBL] [Abstract][Full Text] [Related]
10. Phase II organ-preservation trial: Concurrent cisplatin and radiotherapy for advanced laryngeal cancer after response to docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy.
Popovtzer A; Burnstein H; Stemmer S; Limon D; Hili O; Bachar G; Sopov V; Feinmesser R; Groshar D; Shvero J
Head Neck; 2017 Feb; 39(2):227-233. PubMed ID: 27556178
[TBL] [Abstract][Full Text] [Related]
11. The impact of operability status on outcomes in patients with T4 larynx cancer undergoing larynx preservation.
Schlafstein AJ; Goyal S; Amini A; Karam SD; Saba NF; Kaka AS; Aiken AH; Beitler JJ; Stokes WA
Head Neck; 2022 Dec; 44(12):2854-2864. PubMed ID: 36196859
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches.
Fuller CD; Mohamed AS; Garden AS; Gunn GB; Mulcahy CF; Zafereo M; Phan J; Lai SY; Lewin JS; Hutcheson KA; Frank SJ; Beadle BM; Morrison WH; El-Naggar AK; Kocak-Uzel E; Ginsberg LE; Kies MS; Weber RS; Rosenthal DI
Head Neck; 2016 Dec; 38(12):1739-1751. PubMed ID: 27466789
[TBL] [Abstract][Full Text] [Related]
13. Larynx preservation: what is the best non-surgical strategy?
Lagha A; Chraiet N; Labidi S; Rifi H; Ayadi M; Krimi S; Allani B; Raies H; Touati S; Boussen H; Kochbati L; Mezlini A
Crit Rev Oncol Hematol; 2013 Nov; 88(2):447-58. PubMed ID: 23755889
[TBL] [Abstract][Full Text] [Related]
14. American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer.
; Pfister DG; Laurie SA; Weinstein GS; Mendenhall WM; Adelstein DJ; Ang KK; Clayman GL; Fisher SG; Forastiere AA; Harrison LB; Lefebvre JL; Leupold N; List MA; O'Malley BO; Patel S; Posner MR; Schwartz MA; Wolf GT
J Clin Oncol; 2006 Aug; 24(22):3693-704. PubMed ID: 16832122
[TBL] [Abstract][Full Text] [Related]
15. Optimal sequencing of chemoradiotherapy for locally advanced laryngeal cancer.
; ; . PubMed ID: 30628077
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
